• TFR cells have a dual function in regulating FVIII immune responses.

  • The TFH/TFR pathway is crucial in the development of FVIII inhibitors.

Abstarct

Developing anti–factor VIII (FVIII) inhibitory antibodies (inhibitors) are a significant complication of FVIII protein replacement therapy in hemophilia A. Our previous study demonstrated that follicular helper T (TFH) cells play a critical role in FVIII inhibitor development. Follicular regulatory T (TFR) cells are a subset of forkhead box protein P3 positive (Foxp3+) T cells identified in the germinal center that can modulate TFH cell activation of B cells and antibody development. Here, we report that FVIII immunization significantly increases the TFR cells in the spleens of FVIII inhibitor-producing FVIIInull mice compared with saline-treated controls and non–inhibitor-producing animals. The TFH/TFR ratio significantly increased in FVIII inhibitor-producing mice. The emergence of TFR cells correlated with titers of FVIII inhibitors in FVIII-immunized mice. Using TFR-deficient Foxp3Cre+Bcl6fl/fl (Bcl6FC) mice, we found that the loss of TFR cells led to significantly decreased FVIII inhibitors compared with wild-type (WT) mice on FVIII immunization (24 ± 16 and 131 ± 114 Bethesda unit (BU)/mL, respectively) but not total anti-FVIII IgG levels and that TFR cells regulated IgG subclass switching and FVIII-specific B-cell responses. Interestingly, on FVIII immunization, mice with phosphatase and tensin (Pten) deficiency in Foxp3+ cells (Foxp3Cre+Ptenfl/fl), a model with augmented TFR cells, developed markedly lower FVIII inhibitor titers (8.1 ± 8.6 BU/mL) than WT controls. When CD4Cre+Bcl6fl/fl mice, a TFH- and TFR-deficient model, were immunized with FVIII, none of the animals developed FVIII inhibitors. In conclusion, FVIII immunization induces TFR cell activation and expansion. TFR cells have a dual function in regulating the development of FVIII inhibitors, and the TFH/TFR pathway is pivotal in FVIII inhibitor development in mice.

1.
Schep
SJ
,
Schutgens
REG
,
Fischer
K
,
Boes
ML
.
Review of immune tolerance induction in hemophilia A
.
Blood Rev
.
2018
;
32
(
4
):
326
-
338
.
2.
Cormier
M
,
Batty
P
,
Tarrant
J
,
Lillicrap
D
.
Advances in knowledge of inhibitor formation in severe haemophilia A
.
Br J Haematol
.
2020
;
189
(
1
):
39
-
53
.
3.
Luo
L
,
Zheng
Q
,
Chen
Z
, et al
.
Hemophilia a patients with inhibitors: mechanistic insights and novel therapeutic implications
.
Front Immunol
.
2022
;
13
:
1019275
.
4.
Gringeri
A
,
Mantovani
LG
,
Scalone
L
,
Mannucci
PM
;
COCIS Study Group
.
Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group
.
Blood
.
2003
;
102
(
7
):
2358
-
2363
.
5.
Walsh
CE
,
Jiménez-Yuste
V
,
Auerswald
G
,
Grancha
S
.
The burden of inhibitors in haemophilia patients
.
Thromb Haemost
.
2016
;
116
(
suppl 1
):
S10
-
S17
.
6.
Pratt
KP
,
Arruda
VR
,
Lacroix-Desmazes
S
.
Inhibitors-recent insights
.
Haemophilia
.
2021
;
27
(
suppl 3
):
28
-
36
.
7.
Cho
S
,
Perry
AM
,
Cheng
AM
,
Wang
C
,
Rico
JF
.
Advances in hemophilia A management
.
Adv Pediatr
.
2022
;
69
(
1
):
133
-
147
.
8.
Healy
JI
,
Dolmetsch
RE
,
Timmerman
LA
, et al
.
Different nuclear signals are activated by the B cell receptor during positive versus negative signaling
.
Immunity
.
1997
;
6
(
4
):
419
-
428
.
9.
Martin
F
,
Oliver
AM
,
Kearney
JF
.
Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens
.
Immunity
.
2001
;
14
(
5
):
617
-
629
.
10.
Gauld
SB
,
Dal Porto
JM
,
Cambier
JC
.
B cell antigen receptor signaling: roles in cell development and disease
.
Science
.
2002
;
296
(
5573
):
1641
-
1642
.
11.
Goodnow
CC
,
Vinuesa
CG
,
Randall
KL
,
Mackay
F
,
Brink
R
.
Control systems and decision making for antibody production
.
Nat Immunol
.
2010
;
11
(
8
):
681
-
688
.
12.
Webb
LMC
,
Linterman
MA
.
Signals that drive T follicular helper cell formation
.
Immunology
.
2017
;
152
(
2
):
185
-
194
.
13.
Tangye
SG
,
Ma
CS
,
Brink
R
,
Deenick
EK
.
The good, the bad and the ugly - TFH cells in human health and disease
.
Nat Rev Immunol
.
2013
;
13
(
6
):
412
-
426
.
14.
Vinuesa
CG
,
Linterman
MA
,
Yu
D
,
MacLennan
IC
.
Follicular helper T cells
.
Annu Rev Immunol
.
2016
;
34
:
335
-
368
.
15.
Reding
MT
,
Okita
DK
,
Diethelm-Okita
BM
,
Anderson
TA
,
Conti-Fine
BM
.
Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII
.
J Thromb Haemost
.
2003
;
1
(
8
):
1777
-
1784
.
16.
Hu
GL
,
Okita
DK
,
Conti-Fine
BM
.
T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects
.
J Thromb Haemost
.
2004
;
2
(
11
):
1908
-
1917
.
17.
Reding
MT
,
Okita
DK
,
Diethelm-Okita
BM
,
Anderson
TA
,
Conti-Fine
BM
.
Epitope repertoire of human CD4(+) T cells on the A3 domain of coagulation factor VIII
.
J Thromb Haemost
.
2004
;
2
(
8
):
1385
-
1394
.
18.
Jones
TD
,
Phillips
WJ
,
Smith
BJ
, et al
.
Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII
.
J Thromb Haemost
.
2005
;
3
(
5
):
991
-
1000
.
19.
Steinitz
KN
,
van Helden
PM
,
Binder
B
, et al
.
CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1∗1501 mice
.
Blood
.
2012
;
119
(
17
):
4073
-
4082
.
20.
Ettinger
RA
,
James
EA
,
Kwok
WW
,
Thompson
AR
,
Pratt
KP
.
HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P
.
Haemophilia
.
2010
;
16
(
102
):
44
-
55
.
21.
James
EA
,
Kwok
WW
,
Ettinger
RA
,
Thompson
AR
,
Pratt
KP
.
T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide
.
J Thromb Haemost
.
2007
;
5
(
12
):
2399
-
2407
.
22.
Jing
W
,
Chen
J
,
Cai
Y
, et al
.
Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice
.
Blood Adv
.
2019
;
3
(
20
):
3099
-
3110
.
23.
Vignali
DA
,
Collison
LW
,
Workman
CJ
.
How regulatory T cells work
.
Nat Rev Immunol
.
2008
;
8
(
7
):
523
-
532
.
24.
Shevach
EM
.
Mechanisms of foxp3+ T regulatory cell-mediated suppression
.
Immunity
.
2009
;
30
(
5
):
636
-
645
.
25.
Josefowicz
SZ
,
Niec
RE
,
Kim
HY
, et al
.
Extrathymically generated regulatory T cells control mucosal TH2 inflammation
.
Nature
.
2012
;
482
(
7385
):
395
-
399
.
26.
Becker-Gotot
J
,
Meissner
M
,
Kotov
V
, et al
.
Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ Tregs
.
J Clin Invest
.
2022
;
132
(
22
).
27.
Miao
CH
,
Harmeling
BR
,
Ziegler
SF
, et al
.
CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice
.
Blood
.
2009
;
114
(
19
):
4034
-
4044
.
28.
Kim
YC
,
Zhang
AH
,
Su
Y
, et al
.
Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T- and B-cell responses
.
Blood
.
2015
;
125
(
7
):
1107
-
1115
.
29.
Adair
PR
,
Kim
YC
,
Zhang
AH
,
Yoon
J
,
Scott
DW
.
Human Tregs made antigen specific by gene modification: the power to treat autoimmunity and antidrug antibodies with precision
.
Front Immunol
.
2017
;
8
:
1117
.
30.
Zhang
AH
,
Yoon
J
,
Kim
YC
,
Scott
DW
.
Targeting antigen-specific B cells using antigen-expressing transduced regulatory T cells
.
J Immunol
.
2018
;
201
(
5
):
1434
-
1441
.
31.
Smith
BM
,
Lyle
MJ
,
Chen
AC
,
Miao
CH
.
Antigen-specific in vitro expansion of factor VIII-specific regulatory T cells induces tolerance in hemophilia A mice
.
J Thromb Haemost
.
2020
;
18
(
2
):
328
-
340
.
32.
Herzog
RW
,
Kuteyeva
V
,
Saboungi
R
,
Terhorst
C
,
Biswas
M
.
Reprogrammed CD4(+) T cells that express FoxP3(+) control inhibitory antibody formation in hemophilia A mice
.
Front Immunol
.
2019
;
10
:
274
.
33.
Sage
PT
,
Sharpe
AH
.
The multifaceted functions of follicular regulatory T cells
.
Curr Opin Immunol
.
2020
;
67
:
68
-
74
.
34.
Zhang
H
,
Sage
PT
.
Role of T follicular helper and T follicular regulatory cells in antibody-mediated rejection: new therapeutic targets?
.
Curr Opin Organ Transplant
.
2022
;
27
(
5
):
371
-
375
.
35.
Chen
Q
,
Dent
AL
.
Nonbinary roles for T follicular helper cells and T follicular regulatory cells in the germinal center response
.
J Immunol
.
2023
;
211
(
1
):
15
-
22
.
36.
Ke
F
,
Benet
ZL
,
Maz
MP
, et al
.
Germinal center B cells that acquire nuclear proteins are specifically suppressed by follicular regulatory T cells
.
Elife
.
2023
;
12
:
e83908
.
37.
Xie
MM
,
Dent
AL
.
Unexpected help: follicular regulatory T cells in the germinal center
.
Front Immunol
.
2018
;
9
:
1536
.
38.
Laidlaw
BJ
,
Lu
Y
,
Amezquita
RA
, et al
.
Interleukin-10 from CD4(+) follicular regulatory T cells promotes the germinal center response
.
Sci Immunol
.
2017
;
2
(
16
):
eaan4767
.
39.
Wu
H
,
Chen
Y
,
Liu
H
, et al
.
Follicular regulatory T cells repress cytokine production by follicular helper T cells and optimize IgG responses in mice
.
Eur J Immunol
.
2016
;
46
(
5
):
1152
-
1161
.
40.
Fu
W
,
Liu
X
,
Lin
X
, et al
.
Deficiency in T follicular regulatory cells promotes autoimmunity
.
J Exp Med
.
2018
;
215
(
3
):
815
-
825
.
41.
Botta
D
,
Fuller
MJ
,
Marquez-Lago
TT
, et al
.
Dynamic regulation of T follicular regulatory cell responses by interleukin 2 during influenza infection
.
Nat Immunol
.
2017
;
18
(
11
):
1249
-
1260
.
42.
Bi
L
,
Sarkar
R
,
Naas
T
, et al
.
Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies
.
Blood
.
1996
;
88
(
9
):
3446
-
3450
.
43.
Zhang
AH
,
Skupsky
J
,
Scott
DW
.
Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice
.
Blood
.
2011
;
117
(
7
):
2223
-
2226
.
44.
Shi
Q
,
Schroeder
JA
,
Kuether
EL
,
Montgomery
RR
.
The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies
.
J Thromb Haemost
.
2015
;
13
(
7
):
1301
-
1309
.
45.
Shrestha
S
,
Yang
K
,
Guy
C
,
Vogel
P
,
Neale
G
,
Chi
H
.
Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses
.
Nat Immunol
.
2015
;
16
(
2
):
178
-
187
.
46.
Xie
MM
,
Chen
Q
,
Liu
H
, et al
.
T follicular regulatory cells and IL-10 promote food antigen-specific IgE
.
J Clin Invest
.
2020
;
130
(
7
):
3820
-
3832
.
47.
Chen
Y
,
Luo
X
,
Schroeder
JA
, et al
.
Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated
.
J Thromb Haemost
.
2017
;
15
(
10
):
1994
-
2004
.
48.
Schroeder
JA
,
Chen
Y
,
Fang
J
,
Wilcox
DA
,
Shi
Q
.
In vivo enrichment of genetically manipulated platelets corrects the murine hemophilic phenotype and induces immune tolerance even using a low multiplicity of infection
.
J Thromb Haemost
.
2014
;
12
(
8
):
1283
-
1293
.
49.
Krishnamoorthy
S
,
Liu
T
,
Drager
D
, et al
.
Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice
.
Cell Immunol
.
2016
;
301
:
30
-
39
.
50.
Hofbauer
CJ
,
Whelan
SF
,
Hirschler
M
, et al
.
Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans
.
Blood
.
2015
;
125
(
7
):
1180
-
1188
.
51.
Luo
X
,
Chen
J
,
Schroeder
JA
, et al
.
Platelet gene therapy promotes targeted peripheral tolerance by clonal deletion and induction of antigen-specific regulatory T cells
.
Front Immunol
.
2018
;
9
:
1950
.
52.
Choi
YS
,
Yang
JA
,
Crotty
S
.
Dynamic regulation of Bcl6 in follicular helper CD4 T (Tfh) cells
.
Curr Opin Immunol
.
2013
;
25
(
3
):
366
-
372
.
53.
Choi
YS
,
Yang
JA
,
Yusuf
I
, et al
.
Bcl6 expressing follicular helper CD4 T cells are fate committed early and have the capacity to form memory
.
J Immunol
.
2013
;
190
(
8
):
4014
-
4026
.
54.
Chung
Y
,
Tanaka
S
,
Chu
F
, et al
.
Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions
.
Nat Med
.
2011
;
17
(
8
):
983
-
988
.
55.
Le Coz
C
,
Oldridge
DA
,
Herati
RS
, et al
.
Human T follicular helper clones seed the germinal center-resident regulatory pool
.
Sci Immunol
.
2023
;
8
(
82
):
eade8162
.
56.
Stevens
FJ
,
Bobrovnik
SA
.
Deconvolution of antibody affinities and concentrations by non-linear regression analysis of competitive ELISA data
.
J Immunol Methods
.
2007
;
328
(
1-2
):
53
-
58
.
57.
Bobrovnik
SA
.
ELISA-based method for determining the affinity of bivalent antibodies of two specificities in a mixture
.
Ukr Biokhim Zh (1999)
.
2000
;
72
(
3
):
133
-
141
.
58.
Aloulou
M
,
Carr
EJ
,
Gador
M
, et al
.
Follicular regulatory T cells can be specific for the immunizing antigen and derive from naive T cells
.
Nat Commun
.
2016
;
7
:
10579
.
59.
Maceiras
AR
,
Fonseca
VR
,
Agua-Doce
A
,
Graca
L
.
T follicular regulatory cells in mice and men
.
Immunology
.
2017
;
152
(
1
):
25
-
35
.
60.
Varthaman
A
,
Lacroix-Desmazes
S
.
Pathogenic immune response to therapeutic factor VIII: exacerbated response or failed induction of tolerance?
.
Haematologica
.
2019
;
104
(
2
):
236
-
244
.
61.
Sage
PT
,
Paterson
AM
,
Lovitch
SB
,
Sharpe
AH
.
The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells
.
Immunity
.
2014
;
41
(
6
):
1026
-
1039
.
62.
Lu
Y
,
Jiang
R
,
Freyn
AW
, et al
.
CD4+ follicular regulatory T cells optimize the influenza virus-specific B cell response
.
J Exp Med
.
2021
;
218
(
3
):
e20200547
.
63.
Patel
SR
,
Lundgren
TS
,
Baldwin
WH
, et al
.
Neutralizing antibodies against factor VIII can occur through a non-germinal center pathway
.
Front Immunol
.
2022
;
13
:
880829
.
64.
Hao
H
,
Nakayamada
S
,
Tanaka
Y
.
Differentiation, functions, and roles of T follicular regulatory cells in autoimmune diseases
.
Inflamm Regen
.
2021
;
41
(
1
):
14
.
65.
Linterman
MA
,
Pierson
W
,
Lee
SK
, et al
.
Foxp3+ follicular regulatory T cells control the germinal center response
.
Nat Med
.
2011
;
17
(
8
):
975
-
982
.
66.
Sage
PT
,
Ron-Harel
N
,
Juneja
VR
, et al
.
Suppression by T(FR) cells leads to durable and selective inhibition of B cell effector function
.
Nat Immunol
.
2016
;
17
(
12
):
1436
-
1446
.
67.
Xie
MM
,
Fang
S
,
Chen
Q
,
Liu
H
,
Wan
J
,
Dent
AL
.
Follicular regulatory T cells inhibit the development of granzyme B-expressing follicular helper T cells
.
JCI Insight
.
2019
;
4
(
16
):
e128076
.
68.
Xie
MM
,
Liu
H
,
Corn
C
, et al
.
Roles of T follicular helper cells and T follicular regulatory cells in autoantibody production in IL-2-deficient mice
.
Immunohorizons
.
2019
;
3
(
7
):
306
-
316
.
69.
Gonzalez-Figueroa
P
,
Roco
JA
,
Papa
I
, et al
.
Follicular regulatory T cells produce neuritin to regulate B cells
.
Cell
.
2021
;
184
(
7
):
1775
-
1789.e19
.
70.
Chen
Q
,
Dent
AL
.
Regulation of the IgE response by T follicular regulatory cells
.
J Allergy Clin Immunol
.
2022
;
150
(
5
):
1048
-
1049
.
71.
Qadura
M
,
Waters
B
,
Burnett
E
, et al
.
Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice
.
Haemophilia
.
2011
;
17
(
2
):
288
-
295
.
72.
Kaufman
RJ
,
Pipe
SW
,
Tagliavacca
L
,
Swaroop
M
,
Moussalli
M
.
Biosynthesis, assembly and secretion of coagulation factor VIII
.
Blood Coagul Fibrinolysis
.
1997
;
8
(
suppl 2
):
S3
-
S14
.
73.
Kaufman
RJ
,
Wasley
LC
,
Dorner
AJ
.
Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells
.
J Biol Chem
.
1988
;
263
(
13
):
6352
-
6362
.
74.
Lai
J
,
Hough
C
,
Tarrant
J
,
Lillicrap
D
.
Biological considerations of plasma-derived and recombinant factor VIII immunogenicity
.
Blood
.
2017
;
129
(
24
):
3147
-
3154
.
75.
Repessé
Y
,
Costa
C
,
Palla
R
, et al
.
Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A
.
Haematologica
.
2019
;
104
(
8
):
e369
-
e372
.
76.
Dasgupta
S
,
Repessé
Y
,
Bayry
J
, et al
.
VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors
.
Blood
.
2007
;
109
(
2
):
610
-
612
.
77.
Pipe
SW
,
Montgomery
RR
,
Pratt
KP
,
Lenting
PJ
,
Lillicrap
D
.
Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A
.
Blood
.
2016
;
128
(
16
):
2007
-
2016
.
78.
Chen
J
,
Schroeder
JA
,
Luo
X
,
Shi
Q
.
The impact of von Willebrand factor on factor VIII memory immune responses
.
Blood Adv
.
2017
;
1
(
19
):
1565
-
1574
.
79.
Swystun
LL
,
Lai
JD
,
Notley
C
, et al
.
The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity
.
J Clin Invest
.
2018
;
128
(
9
):
4057
-
4073
.
80.
Swystun
LL
,
Notley
C
,
Georgescu
I
, et al
.
The endothelial lectin clearance receptor CLEC4M binds and internalizes factor VIII in a VWF-dependent and -independent manner
.
J Thromb Haemost
.
2019
;
17
(
4
):
681
-
694
.
81.
Swystun
LL
,
Ogiwara
K
,
Rawley
O
, et al
.
Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients
.
Blood
.
2019
;
134
(
11
):
880
-
891
.
82.
Shi
Q
,
Carman
CV
,
Chen
Y
, et al
.
Unexpected enhancement of FVIII immunogenicity by endothelial expression in lentivirus-transduced and transgenic mice
.
Blood Adv
.
2020
;
4
(
10
):
2272
-
2285
.
83.
Zerra
PE
,
Cox
C
,
Baldwin
WH
, et al
.
Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A
.
Blood
.
2017
;
130
(
23
):
2559
-
2568
.
84.
Kaczmarek
R
,
Piñeros
AR
,
Patterson
PE
, et al
.
Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cells
.
Blood
.
2023
;
142
(
3
):
290
-
305
.
You do not currently have access to this content.
Sign in via your Institution